March 1, 2024
The Honorable Charles Schumer
Majority Leader
US Senate
S-221 Capitol Building
Washington, DC 20510

The Honorable Mitch McConnell
Minority Leader
US Senate
S-230 Capitol Building
Washington, DC 20510

The Honorable Mike Johnson
Speaker of the House
US House of Representatives
H-232 Capitol Building
Washington, DC 20515

The Honorable Hakeem Jeffries
Minority Leader
US House of Representatives
H-204 Capitol Building
Washington, DC 20515

Re: The Urgent Need to Reauthorize PAHPA
Dear Leaders Schumer and McConnell, Speaker Johnson, and Leader Jeffries,
On behalf of the undersigned organizations, we write to express our strong desire to see thePandemic and All-Hazards Preparedness Act (PAHPA) reauthorized in the same bipartisan
fashion it has been supported since the original authorization 17 years ago.
As you know, PAHPA underpins Department of Health and Human Services (HHS) agencies,programs, and funding authorizations for addressing national health security threats. PAHPA
created the HHS Assistant Secretary for Preparedness and Response (now the Administrationfor Strategic Preparedness and Response) and the Biomedical Advanced Research andDevelopment Authority (BARDA) and provides important congressional oversight and direction
to federal programs related to early warning, prevention, preparedness, and response.
This overall framework expired on September 30, 2023, requiring stopgap, temporary
extensions in the continuing resolution. We encourage Congress to include a comprehensive
five-year PAHPA reauthorization in the next moving legislative vehicle.
The last three PAHPA bills all shared major recurring themes: they all adjusted to the changing
threat landscape, focused on challenges identified since the prior bill, and considerably
strengthened our nation’s health security with each reauthorization.
Our nation’s changing health security threat landscape and the federal government’sresponsibility to protect the American people demand that we work together now to find astrong bipartisan path forward to reauthorize this critical legislation. Whether the next healthsecurity threat is naturally occurring, the result of an accident, or intentionally caused, ourcountry must be in a better position to prevent, prepare for, and respond to such incidents.
Failing to reauthorize PAHPA would have serious effects on our country’s economic wellbeing,
national security, and health security given the rapidly changing threat landscape.
We are hopeful that PAHPA will remain a strong bipartisan legislative framework, as it has
always been. We stand ready to assist you in whatever ways we can to help get this important
law reauthorized this year.
Page 1 of 4

Sincerely (in alphabetical order),1Day Sooner

Association of Public Health Laboratories

3M

Association of State and Territorial Health
Officials

Acadian Ambulance Service, Inc.

Asthma and Allergy Foundation of America

Adaptive Phage Therapeutics

AstraZeneca Pharmaceuticals

Adjuvant Capital, L.P.

ATCC

AdvaMedAtea Pharmaceuticals, Inc.

Aequor Inc.

Bavarian Nordic

Air National Guard

Belfer Center of Science and International
Affairs

Alliance for Biosecurity
Altor Safety

Big Cities Health Coalition

America’s Essential Hospitals

Biocom California

American Academy of Pediatrics

BioCT

American Ambulance Association

BioForward Wisconsin

American Association of Neurological Surgeons
American Clinical Laboratory Association

BioNJ

American College of Emergency Physicians

Biotechnology Innovation Organization (BIO)

American College of Surgeons

Blu Zone Bioscience

American Hospital Association

Bugworks

American Lung AssociationCencora

American Medical Manufacturers Association(AMMA)

Colorado BioScience Association

American Pharmacies

CommonSpirit Health

American Public Health Association

Congress of Neurological Surgeons

American Society for Microbiology

Council of State and Territorial Epidemiologists

American Society of Anesthesiologists

Council of State Bioscience Associations(CSBA)

Antheia, Inc.
Arizona Bioindustry Association, Inc. (AZBio)

Association of American Medical Colleges

Civitas Networks for HealthCodagenix

American Medical Women’s Association

Association for Professionals in Infection
Control and Epidemiology

BioKansas

CSL Seqirus
Emergency Department Practice ManagementAssociation
Emergent BioSolutions

Association of Maternal & Child HealthPrograms
Page 2 of 4

FAHLocus BiosciencesFederation of American Scientists

Lutema USA

FluGen Inc.

Mallinckrodt

George Washington University Disaster
Medicine

Marked By Covid
Mass General Brigham

Georgetown University

MassBioGeorgia Bio

McKesson

Gerontological Society of America

Medical Alley

Ginkgo Bioworks

Medical Countermeasures Coalition

Global Health Investment Corporation

Missouri Biotechnology Association (MOBIO)

Global Health Technologies Coalition

Monod Bio, Inc.

Gryphon Scientific

Morehouse School of Medicine - Atlanta, GA

GSK

Mount Sinai Health System

Hamilton Grace LLC
Health Industry Distributors Association (HIDA)

National Association of County and City Health
Officials

Healthcare Distribution Alliance

National Immigration Law Center

Healthcare Leadership Council

NC Life Sciences Organization

Healthcare Ready

Neuroene Therapeutics

Healthtrek Healthcare LLP

New Mexico Biotechnoiogy & Biomedical
Association (NMBio)Helix

New Orleans BioInnovation CenterHIMSSNewYorkBIO

HIV Medicine Association

NexGen Parks

IAVI
Illinois Biotechnology Innovation Organization
Indiana Health Industry Forum
InDevR Inc.
Infectious Diseases Society of America
INOVIO Pharmaceuticals
Institute for Progress
Johns Hopkins Center for Health Security
Jurata Thin Film, Inc
Life Sciences PA

NightHawk Biosciences
Novavax
Ochsner HealthOhio Life Sciences Association
Oklahoma Bioscience Association
PDS Biotechnology
PharmaJet Inc.
Premier Inc.
Public Health Accreditation Board
READDI Inc.

Page 3 of 4

Research!America

Trinity Health

RS BioTherapeutics, Inc.

TrippBio, Inc.

SAB Biotherapeutics, Inc.

True North BioPharm, LLC

Safe Health Systems

Trust for America’s HealthSanofi

United Safety Technology Inc

SecureBio

United States Pharmacopeia (USP)

Shionogi Inc.

University of Colorado

SIGA Technologies, Inc.

University of Hawaii

Society for Public Health Education

University of Maryland School of Medicine

Soligenix, Inc.

University of Nebraska System

Technologies for Pandemic Defense

Valneva USA

Texas A&M Health Science Center

Vaxess Technologies

Texas Healthcare & Bioscience Institute

Vaxxas Inc

Tonix Pharmaceuticals

Virginia Biotechnology Association

Trauma Anesthesiology Society

Washington State University

cc:
Chair Bernie Sanders
Health, Education, Labor & Pensions Committee
US Senate

Chair Cathy McMorris Rodgers
Energy & Commerce Committee
US House of Representatives

Ranking Member Bill Cassidy
Health, Education, Labor & Pensions Committee
US Senate

Ranking Member Frank Pallone
Energy & Commerce Committee
US House of Representatives

Page 4 of 4